Clinical Trials Sponsored by Aptevo Therapeutics
Total 6303 results
-
Alaunos TherapeuticsUnknownHEPATOCELLULAR CARCINOMAUnited States
-
Sorbent TherapeuticsCompletedHeart FailureUnited States
-
Alaunos TherapeuticsCompletedMelanomaUnited States
-
Alaunos TherapeuticsCompletedSoft Tissue SarcomaUnited States, France, Spain, Belgium, Argentina, Colombia, Israel, India, Romania, Australia, Canada, Singapore, Russian Federation, Brazil, Chile, Germany, Guatemala, Italy, Panama, Poland, United Kingdom
-
Argos TherapeuticsCompleted
-
United TherapeuticsTerminatedPeripheral Vascular Disease | Critical Limb Ischemia | Foot Ulcers | Rest Leg PainUnited States
-
Argos TherapeuticsCompleted
-
Allon TherapeuticsCompletedProgressive Supranuclear PalsyUnited States, Australia, France, Canada, Germany, United Kingdom
-
Intarcia TherapeuticsWithdrawnType 2 DiabetesUnited States
-
Intarcia TherapeuticsWithdrawnType 2 DiabetesUnited States
-
Yaupon TherapeuticsCompletedMycosis FungoidesUnited States
-
Allon TherapeuticsCompletedMild Cognitive Impairment, So StatedUnited States
-
Capstone TherapeuticsCompletedScar Prevention | Scar ReductionUnited States
-
Pathfinder TherapeuticsTerminatedLiver CancerUnited States
-
Alaunos TherapeuticsCompletedAdvanced Solid TumorsUnited States
-
Alaunos TherapeuticsUnknownAdvanced Solid TumorsUnited States
-
Alaunos TherapeuticsUnknownAdvanced CancerUnited States
-
Alaunos TherapeuticsUnknownCancer | Small Cell Lung Cancer | Ovarian Cancer | Thymoma | Osteosarcoma | Non Small Cell Lung Cancer | Malignancy | Testicular CancerUnited States
-
Wellstat TherapeuticsCompletedPancreatic Cancer | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada
-
United TherapeuticsCompletedPulmonary Arterial Hypertension | Renal DysfunctionUnited States
-
Windtree TherapeuticsTerminatedMeconium AspirationUnited States
-
Pathfinder TherapeuticsCompletedLiver CancerUnited States
-
Chelsea TherapeuticsCompletedQTc IntervalUnited States
-
Corcept TherapeuticsCompletedDepressive Disorder, MajorUnited States
-
Pathfinder TherapeuticsCompletedLiver CancerUnited States
-
Chroma TherapeuticsCompletedSafety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid TumoursSolid TumorNetherlands, United Kingdom
-
Mateon TherapeuticsCompleted
-
Aeris TherapeuticsCompleted
-
Acorda TherapeuticsCompletedMultiple SclerosisUnited States, Canada
-
Aegera TherapeuticsTerminatedLeukemiaUnited States, Canada, Germany
-
vTv TherapeuticsCompletedObesityUnited States, Canada
-
Harbor TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Intarcia TherapeuticsCompletedChronic Hepatitis CUnited States, Puerto Rico
-
Precision TherapeuticsCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States
-
Chroma TherapeuticsCompletedAcute Myeloid Leukemia | Multiple Myeloma | Myelodysplastic SyndromeUnited Kingdom
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States
-
DARA TherapeuticsCompleted
-
Celldex TherapeuticsCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Bladder CancerUnited States
-
Celldex TherapeuticsCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Bladder CancerUnited States
-
MediQuest TherapeuticsUnknownRaynaud DiseaseUnited States
-
Allergy TherapeuticsCompletedType I HypersensitivityGermany
-
Allergy TherapeuticsCompletedType I HypersensitivityCanada
-
Allergy TherapeuticsCompletedType I HypersensitivityCanada
-
Allergy TherapeuticsCompleted
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States
-
Aegera TherapeuticsCompletedChronic Pain | Diabetic Peripheral NeuropathyUnited States, Canada, Bulgaria, Romania